Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Page
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Anatomy
Concepts & Ideas
Procedures
Sign-in to see full Profile
Network (preview)
41
Dupont, William
29
Simpson, Jean
24
Jensen, Roy
16
Schuyler, Peggy
11
Gobbi, Helenice
8
Kasami, Masako
8
Olson, Sandra
7
Parl, Fritz
6
Plummer, Dale
5
Sanders, Melinda
5
Vnencak-Jones, Cindy
3
Hellerqvist, Carl
3
Manning, Suzanne
3
McLaren, Bernadette
3
Carter, BA
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Page (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Breyer Joan P; Sanders Melinda E; Airey David C; Cai Qiuyin; Yaspan Brian L; Schuyler Peggy A; Dai Qi; Boulos Fouad; Olivares Maria G; Bradley Kevin M; Gao Yu-Tang; Page David L; Dupont William D; Zheng Wei; Smith Jeffrey R
Heritable variation of ERBB2 and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(4):1252-8.
-
2008: Boulos Fouad I; Dupont William D; Simpson Jean F; Schuyler Peggy A; Sanders Melinda E; Freudenthal Marcia E; Page David L
Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study.
Cancer 2008;113(9):2415-21.
-
2007: Page David L
Why I became a surgical pathologist with interest in breast disease.
Journal of clinical pathology 2007;60(3):251-2.
-
2006: McLaren Bernadette K; Schuyler Peggy A; Sanders Melinda E; Jensen Roy A; Simpson Jean F; Dupont William D; Page David L
Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy.
Cancer 2006;107(6):1227-33.
-
2006: Sanders Melinda E; Page David L; Simpson Jean F; Schuyler Peggy A; Dale Plummer W; Dupont William D
Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies.
Cancer 2006;106(7):1453-61.
-
2005: McLaren Bernadette K; Smith Julia; Schuyler Peggy A; Dupont William D; Page David L
Adenomyoepithelioma: clinical, histologic, and immunohistologic evaluation of a series of related lesions.
The American journal of surgical pathology 2005;29(10):1294-9.
-
2005: Page David L
Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis.
Breast cancer research and treatment 2005;93(3):189-90.
-
2005: Sanders Melinda E; Schuyler Peggy A; Dupont William D; Page David L
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Cancer 2005;103(12):2481-4.
-
2005: Gobbi Helenice; Dupont William D; Parl Fritz F; Schuyler Peggy A; Plummer W Dale; Olson Sandra J; Page David L
Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units.
International journal of cancer. Journal international du cancer 2005;113(5):857-9.
-
2005: McLaren Bernadette K; Gobbi Helenice; Schuyler Peggy A; Olson Sandra J; Parl Fritz F; Dupont William D; Page David L
Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study.
The American journal of surgical pathology 2005;29(1):105-8.
-
2004: Kasami Masako; Jensen Roy A; Simpson Jean F; Page David L
Lobulocentricity of breast hypersecretory hyperplasia with cytologic atypia: infrequent association with carcinoma in situ.
American journal of clinical pathology 2004;122(5):714-20.
-
2004: Page David L
Breast lesions, pathology and cancer risk.
The breast journal 2004;10 Suppl 1():S3-4.
-
2003: Gobbi Helenice; Simpson Jean F; Jensen Roy A; Olson Sandra J; Page David L
Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(9):893-901.
-
2003: Page David L
Special types of invasive breast cancer, with clinical implications.
The American journal of surgical pathology 2003;27(6):832-5.
-
2003: Jensen Roy A; Page David L
Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions.
The American journal of surgical pathology 2003;27(6):828-31.
-
2003: Page David L; Schuyler Peggy A; Dupont William D; Jensen Roy A; Plummer W Dale; Simpson Jean F
Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.
Lancet 2003;361(9352):125-9.
-
2002: Kasami M; Page D L
Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.
Journal of clinical pathology 2002;55(11):879; author reply 879.
-
2001: Simpson J F; Page D L
Pathology of preinvasive and excellent prognosis breast cancer.
Current opinion in oncology 2001;13(6):426-30.
-
2001: Mommers E C; Page D L; Dupont W D; Schuyler P; Leonhart A M; Baak J P; Meijer C J; van Diest P J
Prognostic value of morphometry in patients with normal breast tissue or usual ductal hyperplasia of the breast.
International journal of cancer. Journal international du cancer 2001;95(5):282-5.
-
2001: Gobbi H; Jensen R A; Simpson J F; Olson S J; Page D L
Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
Human pathology 2001;32(8):785-90.
-
2001: Ely K A; Carter B A; Jensen R A; Simpson J F; Page D L
Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting.
The American journal of surgical pathology 2001;25(8):1017-21.
-
2001: Carter B A; Page D L; Schuyler P; Parl F F; Simpson J F; Jensen R A; Dupont W D
No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia.
Cancer 2001;92(1):30-6.
-
2000: Page D L; Simpson J F
Pathology of preinvasive and excellent-prognosis breast cancer.
Current opinion in oncology 2000;12(6):526-31.
-
2000: Ely K A; Tse G; Simpson J F; Clarfeld R; Page D L
Diabetic mastopathy. A clinicopathologic review.
American journal of clinical pathology 2000;113(4):541-5.
-
2000: Kasami M; Gobbi H; Dupont W D; Simpson J F; Page D L; Vnencak-Jones C L
Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in apocrine variety.
Breast (Edinburgh, Scotland) 2000;9(1):23-7.
-
2000: Gobbi H; Arteaga C L; Jensen R A; Simpson J F; Dupont W D; Olson S J; Schuyler P A; Plummer W D; Page D L
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
Histopathology 2000;36(2):168-77.
-
2000: Gobbi H; Tse G; Page D L; Olson S J; Jensen R A; Simpson J F
Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration.
American journal of clinical pathology 2000;113(2):288-94.
-
2000: Carter B A; Jensen R A; Simpson J F; Page D L
Benign transport of breast epithelium into axillary lymph nodes after biopsy.
American journal of clinical pathology 2000;113(2):259-65.
-
2000: Simpson J F; Page D L
The p53 tumor suppressor gene in ductal carcinoma in situ of the breast.
The American journal of pathology 2000;156(1):5-6.
-
1999: Gobbi H; Dupont W D; Simpson J F; Plummer W D; Schuyler P A; Olson S J; Arteaga C L; Page D L
Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia.
Journal of the National Cancer Institute 1999;91(24):2096-101.
-
1999: Simpson J F; Page D L
Pathology of preinvasive and excellent-prognosis breast cancer.
Current opinion in oncology 1999;11(6):442-6.
-
1999: Gobbi H; Atkinson J B; Kardos T F; Simpson J F; Page D L
Inflammatory myofibroblastic tumour of the breast: report of a case with giant vacuolated cells.
Breast (Edinburgh, Scotland) 1999;8(3):135-8.
-
1999: Gobbi H; Simpson J F; Borowsky A; Jensen R A; Page D L
Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence.
Cancer 1999;85(10):2170-82.
-
1999: Dupont W D; Page D L; Parl F F; Plummer W D; Schuyler P A; Kasami M; Jensen R A
Estrogen replacement therapy in women with a history of proliferative breast disease.
Cancer 1999;85(6):1277-83.
-
1999: Gobbi H; Simpson J F; Jensen R A; Coogan A C; Page D L
Prostatic adenocarcinoma with glomeruloid features.
Human pathology 1999;30(1):111-2.
-
1998: Page D L; Simpson J F
Pathology of preinvasive and excellent prognosis breast cancer.
Current opinion in oncology 1998;10(6):498-503.
-
1998: Kasami M; Vnencak-Jones C L; Manning S; Dupont W D; Jensen R A; Page D L
Monoclonality in fibroadenomas with complex histology and phyllodal features.
Breast cancer research and treatment 1998;50(2):185-91.
-
1998: Kasami M; Olson S J; Simpson J F; Page D L
Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: an immunohistochemical study.
Histopathology 1998;32(3):232-8.
-
1998: Page D L; Jensen R A; Simpson J F
Premalignant and malignant disease of the breast: the roles of the pathologist.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(2):120-8.
-
1998: Page D L; Jensen R A; Simpson J F
Routinely available indicators of prognosis in breast cancer.
Breast cancer research and treatment 1998;51(3):195-208.
-
1997: Simpson J F; Page D L
Pathology of preinvasive and excellent-prognosis breast cancer.
Current opinion in oncology 1997;9(6):512-9.
-
1997: Scott M A; Lagios M D; Axelsson K; Rogers L W; Anderson T J; Page D L
Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.
Human pathology 1997;28(8):967-73.
-
1997: Battles O E; Page D L; Johnson J E
Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease.
American journal of clinical pathology 1997;108(1):6-12.
-
1997: Kasami M; Vnencak-Jones C L; Manning S; Dupont W D; Page D L
Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.
The American journal of pathology 1997;150(6):1925-32.
-
1997: Page D L; Johnson J E; Dupont W D
Probabilistic approach to the reporting of fine-needle aspiration cytology of the breast.
Cancer 1997;81(1):6-9.
-
1996: Page D L; Simpson J F
Pathology of preinvasive and excellent-prognosis breast cancer.
Current opinion in oncology 1996;8(6):462-7.
-
1996: Page D L; Salhany K E; Jensen R A; Dupont W D
Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma.
Cancer 1996;78(2):258-66.
-
1996: Page D L
The woman at high risk for breast cancer. Importance of hyperplasia.
The Surgical clinics of North America 1996;76(2):221-30.
-
1996: Page D L; Dupont W D; Jensen R A
Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(1):29-32.
-
1996: Thurman G B; Page D L; Wamil B D; Wilkinson L E; Kasami M; Hellerqvist C G
Acute inflammatory changes in subcutaneous microtumors in the ears of mice induced by intravenous CM101 (GBS toxin).
Journal of cancer research and clinical oncology 1996;122(9):549-53.
-
1995: Page D L; Dupont W D; Rogers L W; Jensen R A; Schuyler P A
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.
Cancer 1995;76(7):1197-200.
-
1995: Pierce D F; Gorska A E; Chytil A; Meise K S; Page D L; Coffey R J; Moses H L
Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(10):4254-8.
-
1995: Johnson J E; Page D L; Winfield A C; Reynolds V H; Sawyers J L
Recurrent mammary carcinoma after local excision. A segmental problem.
Cancer 1995;75(7):1612-8.
-
1995: Page D L; Steel C M; Dixon J M
ABC of breast diseases. Carcinoma in situ and patients at high risk of breast cancer.
BMJ (Clinical research ed.) 1995;310(6971):39-42.
-
1994: Page D L; Simpson J F
Pathology of preinvasive and excellent-prognosis breast cancer.
Current opinion in oncology 1994;6(6):549-53.
-
1994: Jensen R A; Page D L; Holt J T
Identification of genes expressed in premalignant breast disease by microscopy-directed cloning.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(20):9257-61.
-
1994: Dupont W D; Page D L; Parl F F; Vnencak-Jones C L; Plummer W D; Rados M S; Schuyler P A
Long-term risk of breast cancer in women with fibroadenoma.
The New England journal of medicine 1994;331(1):10-5.
-
1994: O'Malley F P; Vnencak-Jones C L; Dupont W D; Parl F; Manning S; Page D L
p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
Laboratory investigation; a journal of technical methods and pathology 1994;71(1):67-72.
-
1994: O'Malley F P; Page D L; Nelson E H; Dupont W D
Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category.
Human pathology 1994;25(2):164-8.
-
1994: Lennington W J; Jensen R A; Dalton L W; Page D L
Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.
Cancer 1994;73(1):118-24.
-
1994: Thurman G B; Russel B A; York G E; Wang Y F; Page D L; Sundell H W; Hellerqvist C G
Effects of group B Streptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumors.
Journal of cancer research and clinical oncology 1994;120(8):479-84.
-
1993: Page D L; Dupont W D
Anatomic indicators (histologic and cytologic) of increased breast cancer risk.
Breast cancer research and treatment 1993;28(2):157-66.
-
1993: O'Malley F; Casey T T; Winfield A C; Rodgers W H; Sawyers J; Page D L
Clinical correlates of false-negative fine needle aspirations of the breast in a consecutive series of 1,005 patients.
Surgery, gynecology & obstetrics 1993;176(4):360-4.
-
1993: Lennington W J; Gray G F; Page D L
Mesenchymal hamartoma of liver. A regional ischemic lesion of a sequestered lobe.
American journal of diseases of children (1960) 1993;147(2):193-6.
-
1993: Hellerqvist C G; Thurman G B; Page D L; Wang Y F; Russell B A; Montgomery C A; Sundell H W
Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus.
Journal of cancer research and clinical oncology 1993;120(1-2):63-70.
-
1993: Jensen R A; Dupont W D; Page D L
Diagnostic criteria and cancer risk of proliferative breast lesions.
Journal of cellular biochemistry. Supplement 1993;17G():59-64.
-
1992: Dutt P L; Baxter J W; O'Malley F P; Glick A D; Page D L
Distant cutaneous metastasis of pleural malignant mesothelioma.
Journal of cutaneous pathology 1992;19(6):490-5.
-
1992: Page D L; Simpson J F
Pathology of preinvasive and excellent-prognosis cancers.
Current opinion in oncology 1992;4(6):1010-6.
-
1992: Page D L; Rogers L W
Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia.
Human pathology 1992;23(10):1095-7.
-
1992: Simpson J F; Page D L
Altered expression of a structural protein (fodrin) within epithelial proliferative disease of the breast.
The American journal of pathology 1992;141(2):285-9.
-
1992: Simpson J F; Dutt P L; Page D L
Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal.
Human pathology 1992;23(6):608-11.
-
1992: Casey T T; Rodgers W H; Baxter J W; Sawyers J L; Reynolds V H; Page D L
Stratified diagnostic approach to fine needle aspiration of the breast.
American journal of surgery 1992;163(3):305-11.
-
1992: Page D L; Dupont W D
Benign breast disease: indicators of increased breast cancer risk.
Cancer detection and prevention 1992;16(2):93-7.
-
1992: Page D L; Dupont W D
Indicators of increased breast cancer risk in humans.
Journal of cellular biochemistry. Supplement 1992;16G():175-82.
-
1991: Page D L; Kidd T E; Dupont W D; Simpson J F; Rogers L W
Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.
Human pathology 1991;22(12):1232-9.
-
1991: Arteaga C L; Johnson M D; Todderud G; Coffey R J; Carpenter G; Page D L
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10435-9.
-
1991: Page D L; Dupont W D
Proliferative breast disease: diagnosis and implications.
Science (New York, N.Y.) 1991;253(5022):915-6.
-
1991: Dupont W D; Page D L
Menopausal estrogen replacement therapy and breast cancer.
Archives of internal medicine 1991;151(1):67-72.
-
1990: Page D L; Simpson J F
Pathology of preinvasive and excellent-prognosis breast cancer.
Current opinion in oncology 1990;2(6):1031-7.
-
1990: Page D L; Dupont W D
Anatomic markers of human premalignancy and risk of breast cancer.
Cancer 1990;66(6 Suppl):1326-35.
-
1990: Page D L; Dupont W D
Premalignant conditions and markers of elevated risk in the breast and their management.
The Surgical clinics of North America 1990;70(4):831-51.
-
1989: Page D L
Pathology of preinvasive and early breast cancer.
Current opinion in oncology 1989;1(2):277-83.
-
1989: Jensen R A; Page D L; Dupont W D; Rogers L W
Invasive breast cancer risk in women with sclerosing adenosis.
Cancer 1989;64(10):1977-83.
-
1989: Dupont W D; Page D L
Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia.
Human pathology 1989;20(8):723-5.
-
1989: Dupont W D; Page D L; Rogers L W; Parl F F
Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk.
Cancer 1989;63(5):948-57.
-
1988: Page D L; Dupont W D; Rogers L W
Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk.
Human pathology 1988;19(2):201-7.
-
1988: Page D L
Anatomic markers of human mammary premalignancy and incipient breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1988;106():65-72.
-
1988: Page D L; Dupont W D
Histopathologic risk factors for breast cancer in women with benign breast disease.
Seminars in surgical oncology 1988;4(4):213-7.
-
1986: Page D L; Dupont W D; Rogers L W
Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.
Cancer detection and prevention 1986;9(5-6):441-8.
-
1985: Page D L; Dupont W D; Rogers L W; Rados M S
Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
Cancer 1985;55(11):2698-708.
-
1982: Page D L; Dupont W D; Rogers L W; Landenberger M
Intraductal carcinoma of the breast: follow-up after biopsy only.
Cancer 1982;49(4):751-8.
Sign-in to see more